Literature DB >> 8390334

Correlative studies of rheumatoid factors and anti-viral antibodies in patients with rheumatoid arthritis.

A S Ferraro1, M M Newkirk.   

Abstract

An analysis of the relationship between the immune response to ubiquitous herpes family viruses, namely Epstein-Barr virus (EBV), cytomegalovirus (CMV), and varicella-zoster virus (VZV) and the presence of rheumatoid factors (RF), which are autoantibodies characteristic of patients with rheumatoid arthritis (RA), was conducted. Antibody profiles (RF, anti-viral antibodies) were monitored in the serum of the RA patients, and in normal individuals. No patient was found to have circulating RF in the absence of anti-viral antibodies. When the patients and normal controls were subdivided according to the presence of serum RF, it was found that when RF were present, the frequency of anti-CMV antibodies, but not anti-EBV or anti-VZV antibodies, was significantly higher (P = 0.02) when compared with RF-negative individuals. The titres of anti-CMV but not anti-VZV antibodies were found to increase in the RA patients with disease duration. To see if these viruses could stimulate RF production in vitro, peripheral blood mononuclear cells (PBMC) isolated from the patients and normal controls were stimulated with viral antigens. PBMC from normal controls, but not from RA patients, appeared to be responsive to viral antigen stimulation and produced RF. These data suggest that the immune response to CMV, to a greater extent than to EBV or VZV, correlates with the presence of RF.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8390334      PMCID: PMC1554776          DOI: 10.1111/j.1365-2249.1993.tb03415.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  42 in total

Review 1.  Human cytomegalovirus. A review of developments between 1970 and 1976. I. Clinical developments.

Authors:  S Michelson-Fiske
Journal:  Biomedicine       Date:  1977-02

2.  Complement-fixing intracellular complexes of IgG rheumatoid factor in rheumatoid plasma cells.

Authors:  E Munthe; J B Natvig
Journal:  Scand J Immunol       Date:  1972       Impact factor: 3.487

3.  Effect of D-penicillamine on serum immunoglobulins and rheumatoid factor.

Authors:  R Bluestone; L S Goldberg
Journal:  Ann Rheum Dis       Date:  1973-01       Impact factor: 19.103

4.  Gamma globulin complexes in synovial fluids of patients with rheumatoid arthritis. Partial characterization and relationship to lowered complement levels.

Authors:  R J Winchester; V Agnello; H G Kunkel
Journal:  Clin Exp Immunol       Date:  1970-05       Impact factor: 4.330

5.  Virus antibodies in serum and synovial fluid of patients with rheumatoid arthritis and other connective tissue diseases.

Authors:  J L Kalliomäki; P Halonen; A Salmi
Journal:  Ann Rheum Dis       Date:  1975-02       Impact factor: 19.103

6.  In vitro synthesis of immunoglobulin by rheumatoid synovial membrane.

Authors:  J D Smiley; C Sachs; M Ziff
Journal:  J Clin Invest       Date:  1968-03       Impact factor: 14.808

7.  Enhanced in vitro synthesis of IgM rheumatoid factor in rheumatoid arthritis.

Authors:  W J Koopman; R E Schrohenloher
Journal:  Arthritis Rheum       Date:  1980-09

8.  Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs.

Authors:  G S Panayi; P Wooley; J R Batchelor
Journal:  Br Med J       Date:  1978-11-11

Review 9.  Rheumatoid factor: its nature, specificity, and production in rheumatoid arthritis.

Authors:  P M Johnson; W P Faulk
Journal:  Clin Immunol Immunopathol       Date:  1976-11

10.  Lymphocytes transformed by Epstein-Barr virus. Induction of nuclear antigen reactive with antibody in rheumatoid arthritis.

Authors:  M A Alspaugh; F C Jensen; H Rabin; E M Tan
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

View more
  6 in total

1.  High positivity of anti-CCP antibodies in patients with Down syndrome.

Authors:  Renato M Nisihara; Thelma L Skare; Marília B G Silva; Iara T Messias-Reason; Nanci P Oliveira; Patricia T Fiedler; Shirley R R Utiyama
Journal:  Clin Rheumatol       Date:  2007-03-27       Impact factor: 2.980

2.  Increased levels of antibodies to cytokeratin 18 in patients with rheumatoid arthritis and ischaemic heart disease.

Authors:  D L Mattey; P T Dawes; N B Nixon; L Goh; M J Banks; G D Kitas
Journal:  Ann Rheum Dis       Date:  2004-04       Impact factor: 19.103

3.  Clinical evaluation of new automated cytomegalovirus IgM and IgG assays for the Elecsys(®) analyser platform.

Authors:  M G Revello; C Vauloup-Fellous; L Grangeot-Keros; J van Helden; Y Dickstein; I Lipkin; A Mühlbacher; T Lazzarotto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-01       Impact factor: 3.267

4.  Role of repetitive antigen patterns for induction of antibodies against antibodies.

Authors:  T Fehr; M F Bachmann; E Bucher; U Kalinke; F E Di Padova; A B Lang; H Hengartner; R M Zinkernagel
Journal:  J Exp Med       Date:  1997-05-19       Impact factor: 14.307

5.  Autoimmune response to U1 small nuclear ribonucleoprotein (U1 snRNP) associated with cytomegalovirus infection.

Authors:  M M Newkirk; W J van Venrooij; G S Marshall
Journal:  Arthritis Res       Date:  2001-04-26

6.  Lack of autoantibody production associated with cytomegalovirus infection.

Authors:  Beth C Marshall; Richard A McPherson; Eric Greidinger; Robert Hoffman; Stuart P Adler
Journal:  Arthritis Res       Date:  2002-06-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.